Filtered By:
Specialty: Internal Medicine
Source: European Journal of Internal Medicine
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 213 results found since Jan 2013.
The association between direct oral anticoagulant concentration upon acute stroke and stroke outcome
CONCLUSION: Among DOAC users who developed IS, low drug concentrations at hospital presentation predicted poor outcomes.PMID:36990874 | DOI:10.1016/j.ejim.2023.03.023
Source: European Journal of Internal Medicine - March 29, 2023 Category: Internal Medicine Authors: Shin-Yi Lin Sung-Chun Tang Ching-Hua Kuo Chih-Hao Chen Yuan-Chang Chao Chih-Fen Huang Jiann-Shing Jeng Source Type: research
Temporal relationship between hyperuricemia and hypertension and its impact on future risk of cardiovascular disease
CONCLUSION: Increased SUA levels probably precede elevated BP, and BP partially mediates the pathway from SUA to incident CVD.PMID:36890009 | DOI:10.1016/j.ejim.2023.02.023
Source: European Journal of Internal Medicine - March 8, 2023 Category: Internal Medicine Authors: Xue Tian Shuohua Chen Penglian Wang Qin Xu Yijun Zhang Xiaoli Zhang Shouling Wu Yanxia Luo Anxin Wang Source Type: research
How low should blood pressure be in patients with chronic coronary and cerebrovascular diseases
This article reviews the evidence, controversies and current state of knowledge regarding intensive BP lowering and the lower thresholds of BP to be achieved in patients with chronic coronary or cerebrovascular diseases.PMID:36631307 | DOI:10.1016/j.ejim.2023.01.007
Source: European Journal of Internal Medicine - January 11, 2023 Category: Internal Medicine Authors: A J Manolis M S Kallistratos M Camafort A Coca Source Type: research
Cardiovascular outcomes and mortality after incident ischaemic stroke in patients with a recent cancer history
CONCLUSIONS: After incident ischaemic stroke, patients with recent cancer history have a lower risk of composite MACE and recurrent stroke outcomes but a higher risk of all-cause mortality when compared with patients without a prior history of cancer.PMID:36549951 | DOI:10.1016/j.ejim.2022.12.006
Source: European Journal of Internal Medicine - December 22, 2022 Category: Internal Medicine Authors: Ralph K Akyea Barbara Iyen Georgios Georgiopoulos Joe Kai Nadeem Qureshi George Ntaios Source Type: research
Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study
CONCLUSIONS: Over 12 months after initiation, apixaban and dabigatran conferred progressive increases in event free time for stroke/SE and MB vs warfarin, whereas rivaroxaban conferred an increase in stroke/SE-free time but a loss in MB-free time vs warfarin.PMID:36456387 | DOI:10.1016/j.ejim.2022.10.021
Source: European Journal of Internal Medicine - December 1, 2022 Category: Internal Medicine Authors: Steven Deitelzweig Allison Keshishian Amiee Kang Aaron Jenkins Nipun Atreja Patricia Schuler Jenny Jiang Huseyin Yuce Xiaoxi Sun Gregory Y H Lip Source Type: research
Endovascular Thrombectomy in Basilar-Artery Occlusion Stroke
Eur J Intern Med. 2022 Nov 21:S0953-6205(22)00413-7. doi: 10.1016/j.ejim.2022.11.023. Online ahead of print.NO ABSTRACTPMID:36424272 | DOI:10.1016/j.ejim.2022.11.023
Source: European Journal of Internal Medicine - November 24, 2022 Category: Internal Medicine Authors: Rahul Gupta Amir Hossein Behnoush Amirmohammad Khalaji Aaqib H Malik Bryan Kluck Cardiovascular Research Study Group Source Type: research
Mobile health-technology integrated care in atrial fibrillation patients with heart failure: A report from the mAFA-II randomized clinical trial
CONCLUSION: A mHealth-technology implemented ABC pathway provides consistent effects on the risks of primary outcome, rehospitalisation and bleeding, in AF patients both with and without HF. However, AF-HF patients may need tailored approaches to improve their overall prognosis, specifically to reduce the risk of recurrent AF, HF and acute coronary syndrome.PMID:36347740 | DOI:10.1016/j.ejim.2022.11.002
Source: European Journal of Internal Medicine - November 8, 2022 Category: Internal Medicine Authors: Yutao Guo Giulio Francesco Romiti Bernadette Corica Marco Proietti Niccol ò Bonini Hui Zhang Gregory Yh Lip mAF-App II trial investigators Source Type: research
Proton pump inhibitors and the risk of cardiovascular events and cardiovascular mortality: A systematic review and meta-analysis of observational studies
CONCLUSION: It is questionable, whether PPI monotherapy constitutes a cardiovascular risk factor.PMID:36195531 | DOI:10.1016/j.ejim.2022.09.021
Source: European Journal of Internal Medicine - October 4, 2022 Category: Internal Medicine Authors: Michael Nolde Nayeon Ahn Tobias Dreischulte Evamaria Krause Florian G üntner Alexander G ünter Roman Gerlach Martin Tauscher Ute Amann Jakob Linseisen Christa Meisinger Sebastian-Edgar Baumeister Ina-Maria R ückert-Eheberg Source Type: research
